Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers

被引:6
|
作者
Warren, Matthew B. [1 ]
Cowen, Philip J. [1 ,2 ]
Harmer, Catherine J. [1 ,2 ]
机构
[1] Univ Oxford, Dept Psychiat, Oxford, England
[2] Univ Oxford, Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England
关键词
St John's wort; hypericum; depression; emotional processing; TERM ANTIDEPRESSANT TREATMENT; HYPERICUM-PERFORATUM; DOUBLE-BLIND; MAJOR DEPRESSION; ATTENTIONAL BIAS; EXTRACT; PLACEBO; MEMORY; RECOGNITION; EXPRESSION;
D O I
10.1177/0269881118812101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The neurocognitive model of antidepressant treatment in depression states that antidepressants work by producing relatively immediate positive shifts in emotional processing, which translate into clinical improvement with time. St John's Wort has shown antidepressant potential in randomised controlled trials; however, its pharmacological actions are broad and it is unknown whether treatment also produces changes in emotional processing. Aims: We investigated whether short-term treatment with St John's wort has similar effects on emotional processing to those reported with other antidepressants such as selective serotonergic reuptake inhibitors. Methods: Forty-eight healthy participants were given St John's wort or placebo treatment for seven days. On day 7 they completed a battery of tasks to measure emotional processing and other elements of cognition. Results: St John's wort treatment produced similar changes to other antidepressants, for example reducing recognition of disgusted faces and attention to fearful faces, while increasing memory for positive words. We failed to find evidence for an effect of St John's wort on other aspects of cognition including working memory. Conclusions: These findings lend support to the theory that the production of early positive biases in emotional processing may be a common feature of all clinically effective antidepressants with diverse pharmacological mechanisms.
引用
收藏
页码:194 / 201
页数:8
相关论文
共 50 条
  • [21] An investigation into the acute nootropic effects of Hypericum perforatum L. (St. John's Wort) in healthy human volunteers
    Ellis, KA
    Stough, C
    Vitetta, L
    Heinrich, K
    Nathan, PJ
    BEHAVIOURAL PHARMACOLOGY, 2001, 12 (03): : 173 - 182
  • [22] The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers
    Siepmann, M
    Kirch, W
    Krause, S
    Joraschky, P
    Mueck-Weymann, M
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 79 - 82
  • [23] A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers
    Walsh, Annabel E. L.
    Huneke, Nathan T. M.
    Brown, Randi
    Browning, Michael
    Cowen, Phil
    Harmer, Catherine J.
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [24] Effect of sub-chronic treatment with jarsin (extract of St John's wort) at two doses on evening salivary cortisol and melatonin in healthy male volunteers
    Franklin, M
    Reed, A
    Murck, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S201 - S202
  • [25] THE EFFECT OF ST. JOHN'S WORT ON THE PHARMACODYNAMIC EFFICACY OF CLOPIDOGREL IN HYPORESPONSIVE VOLUNTEERS AND PATIENTS
    Lau, Wei C.
    Welch, Terrence D.
    Shields, Theresa A.
    Rubenfire, Melvyn
    Gurbel, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [26] Potential of St John's Wort for the treatment of depression: the economic perspective
    Solomon, Daniela
    Ford, Emily
    Adams, Jon
    Graves, Nicholas
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 (02): : 123 - 130
  • [27] No clinically relevant CYP3A induction after St. John’s wort with low hyperforin content in healthy volunteers
    Silke C. Mueller
    Jolanta Majcher-Peszynska
    Ralf G. Mundkowski
    Bernhard Uehleke
    Sebastian Klammt
    Hartwig Sievers
    Romanus Lehnfeld
    Bruno Frank
    Kerstin Thurow
    Guenther Kundt
    Bernd Drewelow
    European Journal of Clinical Pharmacology, 2009, 65
  • [28] No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteers
    Mueller, Silke C.
    Majcher-Peszynska, Jolanta
    Mundkowski, Ralf G.
    Uehleke, Bernhard
    Klammt, Sebastian
    Sievers, Hartwig
    Lehnfeld, Romanus
    Frank, Bruno
    Thurow, Kerstin
    Kundt, Guenther
    Drewelow, Bernd
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (01) : 81 - 87
  • [29] Impaired Glucose Tolerance in Healthy Men Treated with St. John's Wort
    Stage, Tore Bjerregaard
    Damkier, Per
    Christensen, Mette Marie Hougaard
    Nielsen, Lene Buch-Krogh
    Hojlund, Kurt
    Brosen, Kim
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (03) : 219 - 224
  • [30] Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Jiang, XM
    Williams, KM
    Liauw, WS
    Ammit, AJ
    Roufogalis, BD
    Duke, CC
    Day, RO
    McLachlan, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 592 - 599